NewsRx

Search our medical news database

Suicide

Researcher models effects of suicide bombing: results of crowd configurations

Published in Law and Health Weekly, December 1st, 2007

Recent research by Zeeshan-ul-hassan Usmani, a Florida Institute of Technology doctoral student and Fulbright Scholar, indicates that various crowd formations exacerbate or minimize injuries and fatalities in the event of a pedestrian suicide bomb attack. His work was conducted through virtual simulation. It showed that the crowd formation experiencing the worst effects is a circular one, with a 51 percent death rate and 42 percent injury rate, thus reaching 93 percent effectiveness. A person that is in line-of-sight with the attacker, rushing toward the exit or in a stampede was found to be in the least safe position. The safest way to stand or sit in a crowd, Usmani found, was in...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook